Search

Your search keyword '"Abdelgadir, Ayat"' showing total 5 results
Start Over Author "Abdelgadir, Ayat"
5 results on '"Abdelgadir, Ayat"'

1. Non-Multisystem Inflammatory Syndrome in Children—Postacute Sequelae of Paediatric COVID-19: Autoimmune or Autoinflammatory? A Systematic Review of the Reported Cases

Author

AbdelMassih, Antoine Fakhry, primary, Hanafy, Maram Hamed, additional, ElAhmady, Maryam, additional, Kozman, Sylvia, additional, Diab, Nourine, additional, Husseiny, Reem, additional, Deyab, Ashrakat, additional, Mady, Aalaa, additional, Yasser, Alia, additional, AbdelHalim, Amira R., additional, Mohyeldin, Aya, additional, Serour, Aya Sayed, additional, AbdelGadir, Ayat, additional, Abdelaziz, Eslam, additional, ElGhamry, Farida, additional, Amr, Hana, additional, Milad, Karim, additional, Fouda, Lamya, additional, Hesham, Mawada, additional, Riad, Mina Adly, additional, Aoun, Mohamed, additional, AbdelTawab, Rana, additional, Sayed, Rana, additional, ElSenbawy, Salma, additional, Abdelkhalek, Sara ElAhmady, additional, Gamal, Nada, additional, and Omar, Yasmin, additional

Published
2023
Full Text
View/download PDF

2. Non-MIS-C postacute sequelae of COVID-19, is it autoimmune or autoinflammatory? A systematic review of the reported cases

Author

AbdelMassih, Antoine, primary, Hanafy, Maram, primary, ElAhmady, Maryam, primary, Kozman, Sylvia, primary, Diab, Nourine, primary, Husseiny, Reem, primary, Deyab, Ashrakat M, primary, Mady, Aalaa, primary, Yasser, Alya, primary, AbdelHalim, Amira, primary, Mohyeldin, Aya, primary, Serour, Aya Sayed, primary, AbdelGadir, Ayat, primary, Abdelaziz, Eslam, primary, ElGhamry, Farida, primary, Amr, Hana, primary, Milad, Karim, primary, Fouda, Lamya, primary, Hesham, Mawada, primary, Riad, Mina Adly, primary, Aoun, Mohamed, primary, AbdelTawab, Rana, primary, Sayed, Rana, primary, ElSenbawy, Salma, primary, Abdelkhalek, Sara ElAhmady, primary, Gamal, Nada, primary, and Omar, Yasmin, primary

Published
2022
Full Text
View/download PDF

3. PISCovid-1_final_preprint.docx

Author

AbdelMassih, Antoine, primary, Hanafy, Maram, primary, ElAhmady, Maryam, primary, Kozman, Sylvia, primary, Diab, Nourine, primary, Husseiny, Reem, primary, Deyab, Ashrakat M, primary, Mady, Aalaa, primary, Yasser, Alya, primary, AbdelHalim, Amira, primary, Mohyeldin, Aya, primary, Serour, Aya Sayed, primary, AbdelGadir, Ayat, primary, Abdelaziz, Eslam, primary, ElGhamry, Farida, primary, Amr, Hana, primary, Milad, Karim, primary, Fouda, Lamya, primary, Hesham, Mawada, primary, Riad, Mina Adly, primary, Aoun, Mohamed, primary, AbdelTawab, Rana, primary, Sayed, Rana, primary, ElSenbawy, Salma, primary, Abdelkhalek, Sara ElAhmady, primary, Gamal, Nada, primary, and Omar, Yasmin, primary

Published
2022
Full Text
View/download PDF

5. Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse.

Author

Prasad RM, Srivastava S, Wang E, Liu JZ, Gami R, Abdelgadir A, Sharma A, Rayamajhi S, and Tikaria R

Subjects
COVID-19 Vaccines, Humans, Immunization, Passive, Recurrence, Treatment Outcome, COVID-19 Serotherapy, COVID-19 diagnosis, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Rituximab adverse effects, Rituximab therapeutic use
Abstract

Introduction: Relapsing COVID-19 infections have been reported, but their etiology and severity are still unknown. In addition, there have been no cases in the literature that associate relapsing infection with immunosuppression, either from a disease course or medications., Case Presentation: This case series illustrates two patients who developed a relapsed infection, likely from recent rituximab infusions. In addition, both cases depicted a severe form of infection than the initial one. Laboratory investigations revealed these patients were unable to produce COVID-19 antibodies, even though one of the patients received convalescent plasma., Conclusion: Clinicians should be aware of the possibility of relapsing COVID-19, especially in immunosuppressed patients. Because rituximab induces B-cell depletion, it can also decrease the effectiveness of the COVID-19 vaccine. Therefore, these patients should receive the vaccine before their scheduled rituximab infusion.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results